BioMarin Pharmaceuticals
BMRN
BMRN
554 hedge funds and large institutions have $16.3B invested in BioMarin Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 195 increasing their positions, 202 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% less capital invested
Capital invested by funds: $18B → $16.3B (-$1.71B)
19% less call options, than puts
Call options by funds: $181M | Put options by funds: $222M
57% less funds holding in top 10
Funds holding in top 10: 14 → 6 (-8)
Holders
554
Holding in Top 10
6
Calls
$181M
Puts
$222M
Top Buyers
| 1 | +$434M | |
| 2 | +$142M | |
| 3 | +$133M | |
| 4 |
Millennium Management
New York
|
+$96.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$77.8M |
Top Sellers
| 1 | -$372M | |
| 2 | -$183M | |
| 3 | -$92.8M | |
| 4 |
Parnassus Investments
San Francisco,
California
|
-$85.3M |
| 5 |
Morgan Stanley
New York
|
-$76M |